Detailed answers about ACCELERATING CLINICAL TRIALS LTD, including incorporation, status, business activity, and accounts information.
When was ACCELERATING CLINICAL TRIALS LTD founded?
ACCELERATING CLINICAL TRIALS LTD was officially incorporated on 19 November 2021 and is registered under company number 13754540. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is ACCELERATING CLINICAL TRIALS LTD?
PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital). This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations.
What is the current status of ACCELERATING CLINICAL TRIALS LTD?
ACCELERATING CLINICAL TRIALS LTD's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does ACCELERATING CLINICAL TRIALS LTD do?
ACCELERATING CLINICAL TRIALS LTD operates in the following sector: 86900 - Other human health activities. This provides insight into the company's primary business activity and industry focus.
What is ACCELERATING CLINICAL TRIALS LTD's registered address?
The registered office address of ACCELERATING CLINICAL TRIALS LTD is 48 CHANCERY LANE, LONDON, ENGLAND, WC2A 1JF. This is the official address filed with Companies House for legal and statutory correspondence.
Is ACCELERATING CLINICAL TRIALS LTD financially stable?
The most recent accounts for ACCELERATING CLINICAL TRIALS LTD were made up to 31 December 2024, filed as SMALL. Next accounts are due by 30 September 2026.